Skip to main content

Advertisement

Table 2 Anthropometrical and biochemical characteristics of study subjects: with and without high glycaemia

From: Inverse relation between FASN expression in human adipose tissue and the insulin resistance level

Patients Control High Glycaemia P
BMI 26.18 ± 4.80 29.51 ± 4.29 0.03
SBP 126.70 ± 18.79 137.75 ± 16.38 0.06
DBP 76.35 ± 10.13 77.50 ± 11.68 0.72
W-H 0.89 ± 0.08 0.91 ± 0.07 0.26
Insulin 12.28 ± 6.29 14.93 ± 8.02 0.20
Glucose 83.78 ± 9.40 136.36 ± 52.61 0.01
HbA1c 5.59 ± 0.38 6.70 ± 0.66 0.00
HOMA-IR 2.56 ± 1.38 5.02 ± 2.50 0.01
Cholesterol 201.43 ± 34.37 194.45 ± 52.35 0.68
TG 105.78 ± 49.68 195.64 ± 113.98 0.03
LDL-c 125.36 ± 26.61 110.91 ± 35.28 0.11
HDL-c 53.81 ± 13.35 49.27 ± 12.10 0.29
CRP 5.75 ± 13.89 3.23 ± 2.58 0.55
Adiponectin 18.94 ± 11.68 14.08 ± 5.68 0.16
Leptin 17.32 ± 17.77 26.83 ± 19.96 0.10
FASN 0.27 ± 0.17 0.08 ± 0.03 0.00
PPARγ1 0.07 ± 0.20 0.03 ± 0.03 0.49
PPARγ2 0.01 ± 0.00 0.01 ± 0.01 0.98
  1. Values are presented as means ± SD. BMI, body mass index (Kg/m2); SBP, systolic blood pressure (mm Hg); DBP, diastolic blood pressure (mm Hg); W-H ratio, waist to hip ratio; Insulin (UI/ml); Glycaemia (mg/dl); HbA1c, glycated haemoglobin (%); HOMA-IR, homeostasis model assessment ((gluc mg/dl*insul U/ml)/405); Cholesterol (mg/dl); TG, triglycerides (mg/dl); LDL-c, low density lipoprotein-cholesterol (mg/dl); HDL-c, high density lipoprotein-cholesterol (mg/dl); CRP, c-reactive protein (mg/l); Adiponectin (ng/ml); Leptin (ng/ml); FASN, fatty acid synthase; PPARγ, peroxisome proliferator-activated receptor. Relationship between variables in control and hyperglycemic individuals was assessed by Student's t test.